X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-20 | GLYC | Rock Edwin | Chief Medical Officer | P - Purchase | $0.26 | +305,000 | 680,403 | +81% | +$78,825 | |||||
| M | 2023-09-21 | GLYC | Rock Edwin | Chief Medical Officer | P - Purchase | $1.38 | +65,403 | 375,403 | +21% | +$90,256 | |||||
2022-12-22 | GLYC | Rock Edwin | Chief Medical Officer | P - Purchase | $2.25 | +110,000 | 310,000 | +55% | +$247,500 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |